Craig C. Hopkinson's Net Worth
$6.14 Million
Who is Craig C. Hopkinson?
Craig C. Hopkinson has an estimated net worth of $6.14 Million. This is based on reported shares across multiple companies, which include Alkermes plc., and ALBIREO PHARMA, INC..
SEC CIK
Craig C. Hopkinson's CIK is 0001730048
Past Insider Trading and Trends
2023 was Craig C. Hopkinson's most active year for acquiring shares with 18 total transactions. Craig C. Hopkinson's most active month to acquire stocks was the month of January. 2021 was Craig C. Hopkinson's most active year for disposing of shares, totalling 11 transactions. Craig C. Hopkinson's most active month to dispose stocks was the month of January. 2023 saw Craig C. Hopkinson paying a total of $510,201.03 for 229,830 shares, this is the most they've acquired in one year. In 2021 Craig C. Hopkinson cashed out on 63,670 shares for a total of $896,209.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alkermes plc. (ALKS) Snapshot price: $26.86
EVP R&D, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.54% | -10.47K |
$29.53 | -$309,168.84 | 99.24K |
Scheduled
|
Nov 6
| ||
Form 4
| +4.05% | 4.28K |
$29.57 | -$100,951.98 | 109.71K |
Feb 23 - Feb 26
| |||
Form 4
| +6.92% | 6.83K |
$28.91 | -$157,617.32 | 105.43K |
Feb 22
| |||
Form 4
| +12.13% | 10.67K |
$31.22 | -$266,086.26 | 98.61K |
Feb 18 - Feb 20
| |||
Form 4
| +55.48% | 31.38K |
$26.77 | -$409,045.60 | 87.94K |
Nov 17 - Feb 8
| |||
Form 4
| +13.42% | 6.69K |
$27.77 | -$148,430.65 | 56.56K |
Feb 22 - Feb 23
| |||
Form 4
| +177.13% | 31.87K |
$28.01 | -$448,625.15 | 49.87K |
Feb 18 - Feb 21
| |||
Form 4
| -39.97% | -11.98K |
$24.76 | -$296,649.95 | 17.99K |
Scheduled
|
Feb 23
| ||
Form 4
| +154.00% | 18.18K |
$25.08 | -$271,651.45 | 29.98K |
Scheduled
|
Feb 18 - Feb 22
| ||
Form 4
| +24.28% | 2.31K |
$26.79 | -$28,638.51 | 11.8K |
Feb 16
| |||
Form 4
|
∞
| 9.5K |
$30.60 | -$172,798.20 | 9.5K |
Sep 14
| |||
Form 4
| -100.00% | -882.00 |
$24.60 | -$21,697.20 |
0
|
Scheduled
|
Jun 9
| ||
Form 4
|
∞
| 882 |
$23.50 | -$8,648.00 | 882 |
Jun 7
| |||
Form 4
| -100.00% | -28.92K |
$19.72 | -$570,287.94 |
0
|
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +69.76% | 11.88K |
$19.58 | -$99,583.88 | 28.92K |
Feb 20 - Feb 21
| |||
Form 4
| +14.85% | 2.2K |
$19.79 | -$23,193.88 | 17.04K |
Feb 16
| |||
Form 4/A
| +75.72% | 6.88K |
—
|
—
| 15.96K |
Feb 21
| |||
Form 4
| +6.32% | 882 |
$17.19 | -$6,325.92 | 14.83K |
Jun 7
| |||
Form 4
| +53.65% | 4.87K |
$20.24 | -$40,560.96 | 13.95K |
Feb 20 - Feb 21
| |||
Form 4
| +32.03% | 2.2K |
$17.77 | -$20,826.44 | 9.08K |
Feb 16
| |||
Form 4
| +14.71% | 882 |
$22.83 | -$8,401.44 | 6.88K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +61.90% | 2.29K |
$32.54 | -$35,240.82 | 6K |
Feb 16
| |||
Form 4
| +320.32% | 2.82K |
$34.01 | -$40,063.78 | 3.7K |
Dec 7
| |||
Form 4
|
∞
| 881 |
$48.30 | -$17,822.70 | 881 |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALBIREO PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 10.49K |
—
|
—
| 10.49K |
Dec 1
| |||
| No matching records found | |||||||||